Research on Underlying Causes of Long-term Use of Nasal Decongestants and the Structured Withdrawal of the Decongestant

PHASE4RecruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Rhinitis Medicamentosa
Interventions
DRUG

Mometasone Furoate

Mometasone furoate nasal spray suspension, 50µg/actuation

Trial Locations (1)

9000

RECRUITING

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER